|
CME Certified Initiative Focuses on Improving the Management of Familial Hypercholesterolemia
BALTIMORE, Md.—January 8, 2013—Familial hypercholesterolemia (FH) is a heritable disorder, which in its most severe form can lead to a first myocardial infarction (MI) or other serious cardiovascular event before the age of 50. Therefore, screening and timely identification of these patients is of critical importance.
Based on the latest clinical practice guidelines and emerging evidence regarding new strategies for the management of FH, Med-IQ, an ACCME-accredited provider of continuing medical education (CME), developed a certified CME online activity that focuses on the recognition, diagnosis, and treatment of FH.
 Advances in Familial Hypercholesterolemia Identification and Management: Clinical
Concepts and Expert Insights
In this comprehensive online publication enhanced with audio commentary, expert faculty also review current evidence regarding disease pathophysiology and the translation of contemporary science into effective evaluation and management.
“Available data suggest substantial gaps in the use of conventional and low-cost methods of diagnosing FH,” said William A. Mencia, MD, CCMEP, Vice President of Education and Medical Affairs at Med-IQ. “Lifestyle modifications and available and emerging pharmacologic treatments have the ability to significantly alter the outcomes of this genetic defect, but application of these advancements requires appropriately educated clinicians. Correcting these practice gaps is an important public health priority, as it will help reduce the risk of coronary heart disease (CHD) among patients with FH..”
| Faculty |
| |
Peter P. Toth, MD, PhD
Director of Preventative Cardiology
CGH Medical Center
Sterling, IL
Professor of Clinical Family and Community Medicine
University of Illinois College of Medicine
Peoria, IL
|
|
| |
James Underberg, MS, MD
Clinical Assistant Professor of Medicine
Department of Medicine
New York University Medical School
Medical Director
Bellevue Hospital Lipid Clinic
Bellevue Hospital
New York, NY
|
|
Interested clinicians are invited to learn more by visiting www.Med-IQ.com/a690.
Physicians: Med-IQ is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Med-IQ designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Other: Nurse practitioners, physician assistants, and other healthcare professionals who successfully complete the activity will receive a Statement of Participation indicating the maximum credits available.
Sponsored by Med-IQ.
© 2013 Med-IQ. All rights reserved.
This activity is supported by an educational grant from Genzyme Corporation, a Sanofi company.
For more information, call (toll-free) 866 858 7434, e-mail info@med-iq.com, or visit www.Med-IQ.com/a690.
|
About Med-IQ
Med-IQ, America's most respected provider of continuing medical education (CME), inspires healthcare professionals through award-winning activities that deliver sophisticated outcomes-based educational designs with measurable results in professional competence and performance. Med-IQ is accredited by the Accreditation Council for Continuing Medical Education (ACCME), the California Board of Registered Nursing (CBRN), and the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing medical education to physicians, nurses, and pharmacists, respectively.
Med-IQ, a leader in the development of performance improvement (PI) and quality improvement (QI) CME initiatives, has been recognized by the Alliance for Continuing Education in the Health Professions for our excellence in CE research (William Campbell Felch Award 2013, 2011), educational collaborations (2013), outstanding CME outcomes assessment (2012), and exceptional leadership (Leadership Award 2013, President's Award 2012). To learn more about Med-IQ, visit www.Med-IQ.com, like us on Facebook, follow us on Twitter, connect with us on LinkedIn, and visit our YouTube channel.
For more information, contact: |
close
